Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli

European Journal of Haematology

Volumn 77, Issue 5, 2006, Pages 395-402

  Bertinetti, Cristina ^a   Simon, Frederic ^b   Zirlik, Katja ^a   Heining Mikesch, Kristina ^a   Pfeifer, Dietmar ^a   Osterroth, Frank ^b   Rosenthal, Felicia M ^b   Veelken, Hendrik ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Cellgenix GmbH   (Germany)

Author keywords

Cancer vaccine; Fab fragments; Immunoglobulin idiotypes; Lymphoma

Indexed keywords

BACTERIAL PROTEIN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN LIGHT CHAIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; B CELL LYMPHOMA; BACTERIUM CONTAMINATION; BIOPSY; CLONAL VARIATION; CONTROLLED STUDY; ESCHERICHIA COLI; FOLLICULAR LYMPHOMA; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNIZATION; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION; VACCINATION; VACCINE PRODUCTION;

CANCER VACCINES; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN LIGHT CHAINS; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; VACCINATION;

EID: 33749266001     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00740.x     Document Type: Article

References (17)

1. OSTERROTH F, GARBE A, FISCH P, VEELKEN H. Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells. Blood 2000;95:1342-1349.
2. HSU FJ, CASPAR CB, CZERWINSKI D, KWAK LW, LILES TM, SYRENGELAS A, TAIDI-LASKOWSKI B, LEVY R. Tumor-specific idiotype vaccines in the treatment of patients with Bcell lymphoma - long-term results of a clinical trial. Blood 1997;89:3129-3135.
3. BENDANDI M, GOCKE CD, KOBRIN CB, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999;5:1171-1177.
4. BERGENBRANT S, YI Q, OSTERBORG A, BJORKHOLM M, OSBY E, MELLSTEDT H, LEFVERT AK, HOLM G. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. Br J Haematol 1996;92:840-846.
5. CARROLL WL, THIELEMANS K, DILLEY J, LEVY R. Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods 1986;89:61-72.
6. HAWKINS RE, ZHU D, OVECKA M, WINTER G, HAMBLIN TJ, LONG A, STEVENSON FK. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 1994;83:3279-3288.
7. TIMMERMAN JM, CZERWINSKI DK, DAVIS TA, et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002;99:1517-1526.
8. OSTERROTH F, ALKAN O, MACKENSEN A, LINDEMANN A, FISCH P, SKERRA A, VEELKEN H. Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination. J Immunol Methods 1999;229:141-153.
9. BERTINETTI C, ZIRLIK K, HEINING-MIKESCH K, IHORST G, DIERBACH H, WALLER CF, VEELKEN H. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res 2006;66:4496-4502.
10. ZHU D, MCCARTHY H, OTTENSMEIER CH, JOHNSON P, HAMBLIN TJ, STEVENSON FK. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 2002;99:2562-2568.
11. AARTS WM, BENDE RJ, STEENBERGEN EJ, KLUIN PM, OOMS EC, PALS ST, van NOESEL CJ. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 2000;95:2922-2929.
12. van DONGEN JJ, LANGERAK AW, BRUGGEMANN M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
13. VOENA C, LADETTO M, ASTOLFI M, PROVAN D, GRIBBEN JG, BOCCADORO M, PILERI A, CORRADINI P. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia 1997;11:1793-1798.
14. SEGAL GH, JORGENSEN T, SCOTT M, BRAYLAN RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas. Hum Pathol 1994;25:1276-1282.
15. INOGES S, RODRIGUEZ-CALVILLO M, LOPEZ-DIAZ DE CERIO A, ZABALEGUI N, PEREZ-CALVO J, PANIZO C, HERNANDEZ M, CUESTA B, ROCHA E, BENDANDI M. Feasibility of idiotype vaccination in relapsed B-cell malignancies. Haematologica 2003;88:1438-1440.
16. WOOD P, ELLIOTT T. Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes. J Exp Med 1998;188:773-778.
17. BACIK I, SNYDER HL, ANTON LC, et al. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J Exp Med 1997;186:479-487.